SoftBank Vision Fund 2 led a round valuing the money management platform developer at $1.5bn, four months after its series D.

Gogox, which counts Alibaba, Cainiao, 58 Daojia, Renren and Singapore Press Holdings as shareholders, has received about $100m in a round co-led by Bocom and Cyberport.

GV has contributed to two rounds for the gene-editing technology developer, which publicly launched yesterday with $315m of funding.

Novel TMT returned to help the third-party e-commerce operator, with more than 25 brands in its stable, hike its 2021 funding to $317m.

The Deutsche Telekom and Sonae-backed cybersecurity services provider was valued at $4.3bn in a series F round that took its overall funding to more than $500m.

Access Biotechnology helped the small molecule drug developer increase its total funding to over $300m in a round led by BVF Partners.

SoftBank’s Vision Fund 2 supplied series E funding for the application management platform developer, valuing it above $1bn.

Tigermed and WuXi Biologics took part in the biopharmaceutical company's series D round, which will accelerate the development of its immuno-oncology drug candidates.

Tencent has co-led the digital banking app developer’s series D round, which boosted its overall funding to about $370m.

HSBC and ABN Amro Ventures helped the data analytics software provider complete a series D round reportedly valuing it at a minimum of $800m.